DDEL-19. TREATMENT ADHERENCE OF SELUMETINIB AMONG PATIENTS DIAGNOSED WITH NEUROFIBROMATOSIS TYPE I AND PLEXIFORM NEUROFIBROMA IN THE UNITED STATES

Authors: Xiaoqin Yang, Chi Gao, Sama Ahsan, Theresa Dettling, Yuqian Gu, Azeem Banatwala, Wendy Cheng

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.365

Source: Full article